FDA Clearance Tracker · P010013
NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Sep 28, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Sep 28, 2001
Approved
Time to decision
212 days
Received Feb 28, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P010013
- Device name
- NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
- Applicant
- Hologic, Inc.
- Applicant location
- Malborough, MA
- Received
- Feb 28, 2001
- Decided
- Sep 28, 2001
- Decision
- Approved
- Supplements
- 86 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE NOVASURE(TM) IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM. THE DEVICE IS INTENDED TO ABLATE THE ENDOMETRIAL LINING OF THE UTERUS OF PRE-MENOPAUSAL WOMEN WITH MENORRHAGIA (EXCESSIVE BLEEDING) DUE TO BENIGN CAUSES FOR WHOM CHILDBEARING IS COMPLETE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MNB. The earliest in FDA's data is P970021, decided Dec 12, 1997.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.